WM-S1-001

N/A

Report date: 2025/06/11 10:59:16
NME

Base Information

Drug NameWM-S1-001
Drug Alias NameCompounds (Wellmarker Bio/Biogenetics)CRG inhibitor (Wellmarker Bio/Biogenetics)WM-S1KDDF-201612-12WM-S1-001
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsNerve growth factor receptor Trk-A inhibitors
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsHead and Neck NeoplasmsColonic NeoplasmsCholangiocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWell Marker Bio
China Registration ClassN/A

Develop Information

Active CompaniesWell Marker BioBiogenetics
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsColonic NeoplasmsCholangiocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A